Canaglif 100
- Canaglif, an adjunct medication, aids in improving glycemic control in adults with type 2 diabetes mellitus.
- Its active component, Canagliflozin, inhibits subtype-2 sodium-glucose co-transport protein (SGLT2), facilitating glucose excretion through urine.
- Strict adherence to recommended dosages and administration guidelines ensures safe and effective utilization.
- Canaglif, offered at our pharmacy, is tailored to enhance patient health and well-being.
Siglimet XR 50/500
- Enhance glycemic control with our comprehensive combination medication.
- Innovative tablet merges sitagliptin and metformin HCl for optimized glucose regulation.
- Tailored dosing approach ensures individualized treatment.
- Minimize gastrointestinal side effects while maximizing efficacy.
- Trust in our safe and effective management of type 2 diabetes.